Tag: #BiotechInnovation

The global biotechnology landscape witnessed a pivotal moment this week as Innovent Biologics, a prominent Chinese pharmaceutical enterprise, concluded an unprecedented agreement with the Japanese pharmaceutical titan Takeda. The arrangement, valued at $1.2 billion in initial payment with potential milestone compensations exceeding $10 billion, represents the most substantial transaction ever recorded for Chinese-developed antibody therapeutics.…